Symbiotec Pharmalab Limited (NSEI: SYMBIOTEC)
Health Care · Pharmaceuticals · IN
Rs1,600.60
+1.72% today · +45.8% 1Y
Public summary
A free snapshot of Symbiotec Pharmalab Limited, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Symbiotec Pharmalab Limited (NSEI: SYMBIOTEC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.10B.
Over the last twelve months the share price has gained 45.8%, trading between 934.20 and 1.64K.
Tweenvest scores Symbiotec Pharmalab Limited across four factors: quality 75/100, value 31/100. Its strongest factor is quality.
SYMBIOTEC price history
Key figures
- Market cap
- $1.10B
- Revenue (TTM)
- $101.01M
- P/E
- 77.57
- EPS
- 20.67
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs1,642.40
- 52-week low
- Rs934.20
- Avg volume (3M)
- —
- Shares outstanding
- 64.26M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vetoquinol SAENXTPA: VETO | $1.10B | €86.30 | -0.12% |
| Guilin Sanjin Pharmaceutical Co., Ltd.SZSE: 002275 | $1.10B | CN¥12.46 | -3.56% |
| ST Pharm Co.,Ltd.KOSDAQ: A237690 | $1.10B | ₩70,200.00 | -1.13% |
| Jiangxi Fushine Pharmaceutical Co., Ltd.SZSE: 300497 | $1.10B | CN¥13.60 | -2.44% |
| Shanghai Yizhong Pharmaceutical Co., Ltd.SHSE: 688091 | $1.09B | CN¥35.57 | -3.81% |
| Shandong Lukang Pharmaceutical Co.,Ltd.SHSE: 600789 | $1.08B | CN¥6.88 | -1.85% |
| Aurisco Pharmaceutical Co.,Ltd.SHSE: 605116 | $1.07B | CN¥17.78 | -1.22% |
| Beijing Foyou Pharma CO.,LTDSHSE: 601089 | $1.05B | CN¥15.01 | -0.07% |